Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma

Comprehensive profiling suggested that uLMS represents a molecularly distinct disease from non-uLMS. Although traditional ICI response biomarkers were similar across anatomic subtypes, uLMSs were immune cold compared with non-uLMS. Signals for ICI responsiveness, such as high TIS and immune cell abundance, in some tumors suggest that further research into immunotherapies for LMS is warranted.

Authors

Institutions

Publication Details

Journal
Clinical Cancer Research
Published
2025-03-18
DOI
https://doi.org/10.1158/1078-0432.ccr-24-2503
Citations
1
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
1.52
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma

Jonathan C. Trent, Alexander J. Chou, Abhijeet Kumar, Jaime F. Modiano et al.
1 citations
Clinical Cancer Research
Sarcoma Diagnosis and Treatment
1.52
article

Large-Scale Multiomic Analysis Identifies Anatomic Differences and Immunogenic Potential in Subtypes of Leiomyosarcoma

Jonathan C. Trent, Alexander J. Chou, Abhijeet Kumar, Jaime F. Modiano, Andrea P. Espejo Freire, Kenneth Cardona, Geoffrey T. Gibney, Andrew Elliott, Don S. Dizon, Gina Z. D’Amato, Roman Groisberg, Vaia Florou, Bradley DeNardo, Richard F. Riedel, Michael J. Demeure, Andreas Seeber, Margaret von Mehren, Moh’d Khushman, Galina Lagos
article en
1 citations

Abstract

Comprehensive profiling suggested that uLMS represents a molecularly distinct disease from non-uLMS. Although traditional ICI response biomarkers were similar across anatomic subtypes, uLMSs were immune cold compared with non-uLMS. Signals for ICI responsiveness, such as high TIS and immune cell abundance, in some tumors suggest that further research into immunotherapies for LMS is warranted.

Clinical Cancer ResearchVol. 31(11)
Rutgers, The State University of New Jersey (US), Fox Chase Cancer Center (US), University of Minnesota (US), Hoag Memorial Hospital Presbyterian (US), University of Arizona (US), Innsbruck Medical University (AT), University of Miami (US), Emory University (US), Georgetown University (US), Universität Innsbruck (AT), Washington University in St. Louis (US), Cornell University (US), Brown University (US), Huntsman Cancer Institute (US), MedStar Georgetown University Hospital (US), Piedmont Cancer Institute (US), University of Miami Health System (US), Banner - University Medical Center Tucson (US), Duke Medical Center (US), Caris Life Sciences (United States) (US), Duke University Health System (US), Sylvester Comprehensive Cancer Center (US), Weill Cornell Medicine (US), Rutgers Cancer Institute (US)
Openalex Percentile: Top 21%
Sarcoma Diagnosis and Treatment
1.52
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.